| Literature DB >> 23798908 |
Aaron A Harthan1, Margaret L Heger.
Abstract
The drug of choice for treatment of Stenotrophomonas maltophilia is sulfamethoxazole/trimethoprim, and second-line therapy usually consists of a fluoroquinolone. However, in patients with glucose-6-phosphate dehydrogenase deficiency, neither sulfamethoxazole/trimethoprim nor a fluoroquinolone is a preferred option as it may result in hemolysis. Currently, there is a paucity of data regarding treatment of S maltophilia infection in these patients. This case report presents a patient who was successfully treated with doxycycline and inhaled colistimethate.Entities:
Keywords: G6PD deficiency; Stenotrophomonas; colistimethate; doxycycline
Year: 2013 PMID: 23798908 PMCID: PMC3668942 DOI: 10.5863/1551-6776-18.2.137
Source DB: PubMed Journal: J Pediatr Pharmacol Ther ISSN: 1551-6776